Ocean Bio-Chem Current Liabilities
The Current Liabilities of Ocean Bio-Chem (OBCI) as of Oct 23, 2026 is 6.38 M USD. In the previous year, Current Liabilities was 5.43 M USD — a change of 17.53% (higher).
Get this data via API
Financial Data API
Current Liabilities
6.38 MUSD
YoY
17.53%
Last updated:
The Ocean Bio-Chem Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 6.38 MUSD | +17.53% | |
| 5.43 MUSD | +17.72% | |
| 4.61 MUSD | +1.37% | |
| 4.55 MUSD | +16.31% | |
| 3.91 MUSD | -8.11% | |
| 4.25 MUSD | -19.44% | |
| 5.28 MUSD | -6.62% | |
| 5.66 MUSD | +9.79% | |
| 5.15 MUSD | +2.36% | |
| 5.03 MUSD | -13.75% | |
| 5.83 MUSD | +33.18% | |
| 4.38 MUSD | -10.66% | |
| 4.90 MUSD | -26.05% | |
| 6.63 MUSD | +33.65% | |
| 4.96 MUSD | -0.64% | |
| 4.99 MUSD | -31.76% | |
| 7.32 MUSD | -13.64% | |
| 8.48 MUSD | +5.73% | |
| 8.02 MUSD | +1.70% | |
| 7.88 MUSD | +11.82% | |
| 7.05 MUSD | -2.85% | |
| 7.26 MUSD | +86.03% | |
| 3.90 MUSD | +5.98% | |
| 3.68 MUSD | -10.68% | |
| 4.12 MUSD | +79.13% | |
| 2.30 MUSD | +9.52% | |
| 2.10 MUSD | +1,300.00% | |
| 150,000.00USD | -53.13% | |
| 320,000.00USD | +966.67% | |
| 30,000.00USD | -92.11% | |
| 380,000.00USD | +52.00% | |
| 250,000.00USD | -16.67% | |
| 300,000.00USD | -34.78% | |
| 460,000.00USD | +12.20% | |
| 410,000.00USD | -68.70% | |
| 1.31 MUSD | +13.91% | |
| 1.15 MUSD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Ocean Bio-Chem Stock analysis
Frequently Asked Questions about Ocean Bio-Chem stock
Current Liabilities of Ocean Bio-Chem is 6.38 M USD in 2021.
Current Liabilities of Ocean Bio-Chem changed from 5.43 M USD to 6.38 M USD, representing a 17.53% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Ocean Bio-Chem since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Ocean Bio-Chem historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Balance Sheet — Ocean Bio-Chem
All Key Metrics — Ocean Bio-Chem
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth